ASX - Delayed Quote AUD

IDT Australia Limited (IDT.AX)

0.0950 -0.0020 (-2.06%)
At close: April 26 at 3:25 PM GMT+10
Key Events
Loading Chart for IDT.AX
DELL
  • Previous Close 0.0970
  • Open 0.0970
  • Bid 0.0950 x 8161000
  • Ask 0.1000 x 1749600
  • Day's Range 0.0950 - 0.0980
  • 52 Week Range 0.0500 - 0.1250
  • Volume 169,000
  • Avg. Volume 315,084
  • Market Cap (intraday) 33.391M
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Feb 21, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 12, 2010
  • 1y Target Est --

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

en.idtaus.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: IDT.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IDT.AX
13.64%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

IDT.AX
25.00%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

IDT.AX
75.64%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

IDT.AX
40.63%
S&P/ASX 200 [XJO]
18.64%

Compare To: IDT.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IDT.AX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    33.39M

  • Enterprise Value

    31.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.74

  • Price/Book (mrq)

    1.45

  • Enterprise Value/Revenue

    3.07

  • Enterprise Value/EBITDA

    -4.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -63.35%

  • Return on Assets (ttm)

    -17.53%

  • Return on Equity (ttm)

    -27.94%

  • Revenue (ttm)

    10.33M

  • Net Income Avi to Common (ttm)

    -6.54M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.16M

  • Total Debt/Equity (mrq)

    9.97%

  • Levered Free Cash Flow (ttm)

    -8.43M

Company Insights: IDT.AX

People Also Watch